These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1524924)

  • 21. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program.
    Oestreicher N; Lehman CD; Seger DJ; Buist DS; White E
    AJR Am J Roentgenol; 2005 Feb; 184(2):428-32. PubMed ID: 15671358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [For an intensive strategy for surveillance after treatment of breast cancer].
    Sebban E
    Gynecol Obstet Fertil; 2006 Mar; 34(3):268-70. PubMed ID: 16529970
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening by mammography, women with a family history of breast cancer.
    Lalloo F; Boggis CR; Evans DG; Shenton A; Threlfall AG; Howell A
    Eur J Cancer; 1998 May; 34(6):937-40. PubMed ID: 9797712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Not Available].
    Gautier CP; Tournoux-Facon C; Rymzhanova R
    Sante Publique; 2016 Oct; 28(4):481-486. PubMed ID: 28155752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds.
    Holland PA; Walls J; Boggis CR; Knox F; Baildam AD; Bundred NJ
    Br J Cancer; 1996 Nov; 74(10):1643-6. PubMed ID: 8932348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open letter to panels that are deciding guidelines for breast cancer screening.
    Kopans DB
    Breast Cancer Res Treat; 2015 May; 151(1):19-25. PubMed ID: 25868866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history of breast cancer--can anything be done about it?
    Sacks NP
    Med Leg J; 2000; 68 ( Pt 1)():16-29. PubMed ID: 10858672
    [No Abstract]   [Full Text] [Related]  

  • 29. [Risk of invasive breast cancer in Mexican population and patterns of screening and prophylaxis].
    Medina-Franco H; Garza E; Gabilondo B; Gaona-Luviano P
    Rev Invest Clin; 2004; 56(4):422-6. PubMed ID: 15587286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: The continued utility of needle localised biopsy for non-palpable breast lesion, Hemmer et al.
    Besic N; Zgajnar J; Hocevar M
    Eur J Surg Oncol; 2004 Oct; 30(8):907. PubMed ID: 15336739
    [No Abstract]   [Full Text] [Related]  

  • 31. Aspects in mammographic screening. Detection, prediction, recurrence and prognosis.
    Thurfjell MG
    Acta Radiol Suppl; 2001 Dec; 42(424):1-22. PubMed ID: 12040855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comparative analysis of interval breast cancer with breast cancer detected by mass screening or in outpatient clinics].
    Komaki K; Morimoto T; Oshimo K; Mori T; Sasa M; Konishi Y; Monden Y
    Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):413-8. PubMed ID: 1603047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower sensitivity of screening mammography after previous benign breast surgery.
    van Breest Smallenburg V; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; van Beek M; Louwman MW
    Int J Cancer; 2012 Jan; 130(1):122-8. PubMed ID: 21328339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness.
    Costantini M; Belli P; Rinaldi P; Bufi E; Giardina G; Franceschini G; Petrone G; Bonomo L
    Clin Radiol; 2010 Dec; 65(12):1005-12. PubMed ID: 21070905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["Breast charter 2004". Diagnostic approach to breast pathology].
    Di Maggio C; Del Favero C; Frigerio A; Giuseppetti GM; Gozzi G; Lattanzio E; Pesce B; Rosselli Del Turco M; Simonetti G; Nosenzo MA
    Radiol Med; 2004; 108(5-6):569-87. PubMed ID: 15723003
    [No Abstract]   [Full Text] [Related]  

  • 38. Biologic Profiles of Invasive Breast Cancers Detected Only With Digital Breast Tomosynthesis.
    Kim JY; Kang HJ; Shin JK; Lee NK; Song YS; Nam KJ; Choo KS
    AJR Am J Roentgenol; 2017 Dec; 209(6):1411-1418. PubMed ID: 28834445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological features, DNA content and prognosis of breast carcinoma found incidentally or in screening.
    Joensuu H; Toikkanen S; Klemi PJ
    Br J Cancer; 1991 Sep; 64(3):588-92. PubMed ID: 1911203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Invasive micropapillary carcinoma of breast: clinicopathologic significance and recent advances].
    Fu L
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):79-82. PubMed ID: 18681316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.